|
Market Closed -
Nasdaq
16:00:00 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 1.920 USD | -4.95% |
|
+3.78% | +23.08% |
| 09-16 | Novartis halts ALS drug development after mid-stage trial failure | RE |
| 09-15 | Alector, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 07:00 AM |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ALEC | Delayed | |
CBOE
| ALEC | Real-time | |
|
Deutsche Boerse AG
| 0Z2 | Delayed | |
|
Börse Stuttgart
| 0Z2 | Delayed | |
|
Tradegate
| 0Z2 | Real-time | |
|
Boerse Muenchen
| 0Z2 | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 2.26 | 2.72 | 3.04 |
| Spread/Res. | -15.04% | -29.41% | -36.84% |
| Spread/Supp. | +3.78% | +38.13% | +57.38% |
| Support | 1.85 | 1.39 | 1.22 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ALEC Stock
- Charts Alector, Inc.
Select your edition
All financial news and data tailored to specific country editions
